Home | Articles
Published on:September 2022
Indian Journal of Pharmaceutical Education and Research, 2022; 56(4):1226-1231
Original Article | doi:10.5530/ijper.56.4.204

The Prevalence of Anemia and Hematological Findings in COVID-19 Patients in Saudi Arabia


Authors and affiliation (s):

Mazen Almehmadi1,*, Magdi Salih1, Ayman Al-hazmi1, Muhannad Alenazi1, Osama Abdulaziz1, Faisal Almalki1, Alaa Shafie1, Naif Alsiwiehri1, Mamdouh Allahyani1, Njoud Althibity2, Ebtisam Alosimi2, Abdullah Turjoman5, Fatimah Rebh3, Abdulelah Aljuaid1, Mustafa Halawi4

1Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, SAUDI ARABIA.

2Department of Chemistry, College of Sciences, Taif University, Taif, SAUDI ARABIA.

3Department of Internal Medicine, Section of Infectious Diseases, Prince Mohammed Bin Abdulaziz Hospital, Riyadh, SAUDI ARABIA

4Department of Medical Laboratory Technology, College of Applied Medical Sciences, Jazan University, Jazan, SAUDI ARABIA.

5Department of Clinical Laboratory, Prince Mohammed Bin Abdulaziz Hospital, Riyadh, SAUDI ARABIA.

Abstract:

Objectives: The aim of this study was to estimate the prevalence of anemia among COVID-19 patients in Saudi Arabia and evaluate their hematological parameters. Materials and Methods: A descriptive, cross-sectional, hospital-based study was conducted between February 2021 to March 2021, data collection covered the period between September 2020 to March 2021. All the patients were hospitalized for confirmed COVID-19. Results: A total of 6048 COVID-19 patients included in our study, 2358 (48.9%) were anemic, 3666 (60.61%) were normal HGB level, and only 24 (0.49%) were having polycythemia. Hemoglobin level ranged from 5 g/dL to 18 g/dL with a median (interquartile range) of 11.8 g/dL (8.9 to 13.1) g/dL. The median for male (interquartile range) was for anemic patient’s 9.8 g/dL (8.5 to 11.4) g/dL, normal 14 g/dL (13.5 to 14.8) g/dL, and polycythemia 17.4 g/dL (17.2 to 17.7) g/dL. The median for female (interquartile range) was for anemic patient’s 9.1 g/dL (8.2 to 10.2) g/dL, normal 13.5 g/ dL (12.5 to 14.5) g/dL, and polycythemia 17 g/dL (16.82 to 17.2) g/dL. Hematological parameters detected are indicative of severe complications in anemic patients compared to non-anemic patients. Conclusion: Our findings were consistent with other studies that reported poor outcomes of anemia in COVID-19 patients.

Keywords: Anemia, Polycythemia, COVID-19, Hematological factors, CBC.

 




 

Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the Latest Release of Journal Citation Reports (source: Web of Science Data).

 

Impact Factor® as reported in the 2021 Journal Citation Reports® (Clarivate Analytics, 2022): 0.843

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs